Comparison of artefact reduction possibilities with the new active transcutaneous bone conduction implant (Bonebridge).


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 12 2 2022
medline: 3 3 2023
entrez: 11 2 2022
Statut: ppublish

Résumé

This study aimed to evaluate the possibilities of artefact reduction using different anatomical implant positions with the Bonebridge bone-conduction hearing implant 602 for a patient with an acoustic neuroma requiring regular diagnostic magnetic resonance imaging of the tumour position. Three implant positions and magnetic resonance imaging examinations with and without customised sequences for metal artefact suppression were investigated. The diagnostic usefulness was rated by a radiologist (qualitative evaluation), and the relation between the area of artefact and the total head area was calculated (quantitative evaluation). Following the qualitative analysis, the radiologist rated the superior to middle fossa implant placement significantly better for diagnostic purposes, which is in agreement with the calculated artefact ratio ( The application of artefact reduction sequencing and special anatomical implant positioning allows regular magnetic resonance imaging in patients with the bone-conduction hearing implant 602 without sacrificing diagnostic imaging quality for tumour diagnosis.

Identifiants

pubmed: 35144697
doi: 10.1017/S0022215122000494
pii: S0022215122000494
pmc: PMC9975762
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-269

Références

Acta Otolaryngol. 2016;136(3):241-4
pubmed: 26624271
J Laryngol Otol. 2018 May;132(5):401-403
pubmed: 29683103
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):45-52
pubmed: 25411817
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3203-3209
pubmed: 32965538
Med Devices (Auckl). 2015 Jan 16;8:79-93
pubmed: 25653565
Radiography (Lond). 2018 May;24(2):e25-e30
pubmed: 29605121
Semin Perinatol. 2013 Oct;37(5):334-9
pubmed: 24176156
Otol Neurotol. 2018 Aug;39(7):e557-e560
pubmed: 29995009
Otolaryngol Clin North Am. 2012 Apr;45(2):487-511, x-xi
pubmed: 22483829
Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2079-82
pubmed: 24639341
J Laryngol Otol. 2019 Apr;133(4):344-347
pubmed: 30932803
Arch Otolaryngol Head Neck Surg. 2005 Mar;131(3):241-4
pubmed: 15781765
PLoS One. 2019 Sep 16;14(9):e0221484
pubmed: 31525208
Otol Neurotol. 2018 Feb;39(2):e80-e86
pubmed: 29210950
Acta Otolaryngol. 2007 Oct;127(10):1051-7
pubmed: 17851885
Eur J Radiol. 2008 Feb;65(2):214-21
pubmed: 18312784
HNO. 2017 Jan;65(Suppl 1):35-40
pubmed: 26886493
Auris Nasus Larynx. 2014 Feb;41(1):84-7
pubmed: 23722197
Otol Neurotol. 2004 Nov;25(6):969-72
pubmed: 15547427
Eur J Radiol. 2008 Feb;65(2):222-7
pubmed: 18096342

Auteurs

S Edlinger (S)

Department of Otorhinolaryngology, Head and Neck Surgery, University Clinic St Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St Poelten, Austria.

E Tenner (E)

Department of Otorhinolaryngology, Head and Neck Surgery, University Clinic St Poelten, Austria.

J Frühwald (J)

Institute for Radiology, St Poelten, Austria.

G Sprinzl (G)

Department of Otorhinolaryngology, Head and Neck Surgery, University Clinic St Poelten, Austria.
Karl Landsteiner Institute of Implantable Hearing Devices, St Poelten, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH